06Jun

At the start of the new year, 28 U.S. states increased their minimum wage. Beginning January 1, 2023, more than half of the country accounted for the cost of living and recent inflation. In the past few years since the hit of the COVID-19 pandemic, working conditions and pay drastically shifted and subsequently demanded the labor market to adapt accordingly.  

Wage increases often spark debate over necessity, as well as its pros and cons. As part of the staffing industry, Green Key Resources recruiters pay attention to these changes and how they will affect their clients and candidates. Emily Gelman, Professional Services Recruiter at Green Key, elaborates on the ways she expects her industry to change. 

In terms of positive shifts, Emily believes wage increases will bring along higher productivity in the workplace. “If employees are getting paid more, they are likely to bring more to the table when it comes to their job duties,” she says. “Although money is not everything when it comes to a career, it’s a large driving factor for most. For some, this may mean not having to work two jobs, which equates to a stronger focus on one position.” 

Additionally, Emily reiterates the boost in job satisfaction she predicts to see among her candidates. With more financial security, professionals are more likely to appreciate their career and colleagues. “Employees will feel more satisfied with their jobs. Job satisfaction translates into higher levels of collaboration, creativity, and communication,” Emily says. 

This isn’t to say there can’t be challenges due to wage increases. Recruiters need to be aware of the consequences when communicating with their clients and candidates. For instance, when professionals become aware of how much entry-level employees are now making, they might respond by demanding a higher paycheck.  

“With this wage increase, we will have to educate our clients on the matter and push for higher rates,” Emily mentions. “Most fast-food chains and retail stores will be paying this minimum as well, so we need to make sure our clients know that they will get quality results if they reflect that in their pay rates.” 

Regardless, raising the minimum wage was deemed necessary in most states. CNN attributes the demand to the pandemic and subsequent work shortages. They say, “Employers have found themselves short of workers for most of the year, which has pushed up average annual hourly wages in the battle to recruit and retain staff. While some workers in competitive industries such as retail and dining have found their new salary outpaces inflation, most pay has been outpaced by rising prices.” 

As we begin the year and these new wages take effect, don’t hesitate to reach out to one of Green Key’s talented recruiters either on LinkedIn or our website. Our recruiters will be more than happy to work with you on your job-hunting journey and discuss important topics such as wages! 

Jun 6, 2023

Family Doctors Are In Demand Everywhere

Family physicians are the most recruited of all doctors. The demand for these family practitioners is expected to grow by 10%, second only to psychiatrists. Yet those who practice family medicine have seen their average pay decrease, making these doctors among the lowest paid of all medical specialties.

To 10 states highest doctor pay - blog.jpg

These aren’t new revelations, but they stand out starkly in the just-released Physician Compensation Report from Physicians Thrive, a financial advisory firm for doctors. The report is a compilation of data from multiple sources. It covers pay and bonuses by physician specialty and practice, and drills down into regional and state differences, hiring demand, and gender gap issues.

The report tells us that in 2020 specialists earned an average $346,000 per year, up from $341,000 in 2019. But female physicians earn 28% less on average than their male counterparts in the same specialty.

Primary care physicians, including family medicine practitioners, earn an average of $243,000 per year, up from $237,000 in 2019. But half of all family medicine doctors earn less than $205,000. And they’ve seen their pay decrease by 8.3%, the largest of all medical specialties, according to the report.

Why isn’t clear.

It’s not a matter of a significant gender imbalance the way it is in pediatrics where almost two-thirds of the doctors are women. Or in obstetrics/gynecology, which is 59% female. The Association of American Medical Colleges says 59% of the family medicine doctors are male.

For whatever reason, the Physicians Thrive report says that, “Since 2014, the number of physicians choosing to work in family medicine has decreased, leaving family practices understaffed throughout the country.”

Picking up at least some of the slack are nurse practitioners and physician assistants. The report says 78% of NPs and 33% of PAs provide primary care, according to the report. Though they do much of the same work as a physician, nurse practitioners on average earned $124,000 in 2019.

The highest-paid specialists, according to the report, are neurosurgeons earning a median of $645,000. In the Midwest, these specialists earn an average of $760,000 annually, making them the highest-paid specialists anywhere.

Photo by CDC on Unsplash

[bdp_post_carousel]

Jun 6, 2023

Bioscience Rushing to Develop Virus Vaccines and Treatments

Big pharma and small bioscience are taking on the coronavirus, some becoming collaborators, some going it alone.

At least 21 companies are working on a vaccine or treatment, according to MarketWatch. A few of the larger firms are financing the development themselves or with partners. The larger share are being funded by the Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases (NIAID). Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) is funding others.

Several of the companies are testing the efficacy of their existing drugs to treat COVID-19 directly or as therapies to reduce the severity of the virus.

Gilead Sciences, for example, is conducting clinical trials of its antiviral drug Remdesivir. The drug was made available in the US to 1,700 COVID-19 patients on a compassionate use basis. It showed promise, but the sample size was too small to draw broad conclusions. Now, Gilead is conducting several clinical trials in the US and elsewhere. A randomized, controlled clinical trial is underway in Wuhan, China, where the coronavirus was first detected.

A vaccine under development by bioscience startup Heat Biologics in partnership with the University of Miami Miller School of Medicine is among the World Health Organization’s “draft landscape” of 41 candidate vaccines. A different vaccine based on DNA is in phase 1 clinical trial by Inovio Pharmaceuticals. Inovio was given a $5 million grant from the Bill & Melinda Gates Foundation to test a delivery device. It also received $9 million from the Coalition for Epidemic Preparedness Innovations.

Photo by Hakan Nural on Unsplash

[bdp_post_carousel]